Aclaris Therapeutics, Inc. (0H8T)
Market Closed
26 Oct, 03:30 PM
LSE 
$
3. 80
+0.11
+2.981%
$
- Market Cap
- P/E Ratio
- Div Yield
358 Volume
-1.64 Eps
$ 3.69
Previous Close Want to track 0H8T and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aclaris Therapeutics, Inc. (0H8T) Statistics
Valuation metrics
Market Cap -
Enterprise value 532.83M
Trailing P/E (ttm) -6.47
Forward P/E -
PEG ratio -0.14
Price/Sales (ttm) 67.16
Price/Book (mrq) 4.3
Enterprise Value/Revenue 64.83
Enterprise Value/EBITDA -7.07
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.56K
Average volume (90 days) 2.94K
Price summary
52-Week low 2.11
52-Week high 6.58
Beta -
50-Day moving average 4.63
200-Day moving average 4.93
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -9.21%
Operating margin -10.5%
Operational effectiveness
Return on assets -0.42%
Return on equity -0.62%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.53
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.64
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 3.46%
Book value per share (mrq) 0.87
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
